Covestro AG
Covestro AG (CVVTF) Financial Performance & Income Statement Overview
Explore the financials of Covestro AG (CVVTF), including yearly and quarterly data on income, cash flow, and balance sheets.
Covestro AG (CVVTF) Income Statement & Financial Overview
Analyze Covestro AG’s CVVTF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $3.48B | $3.38B | $3.60B | $3.69B |
| Cost of Revenue | $3.01B | $3.01B | $3.03B | $3.05B |
| Gross Profit | $465.00M | $362.00M | $571.00M | $640.00M |
| Gross Profit Ratio | $0.13 | $0.11 | $0.16 | $0.17 |
| R&D Expenses | $90.00M | $118.00M | $85.00M | $98.00M |
| SG&A Expenses | $477.00M | $482.00M | $445.00M | $474.00M |
| Operating Expenses | $562.00M | $553.00M | $530.00M | $572.00M |
| Total Costs & Expenses | $3.57B | $3.57B | $3.53B | $3.62B |
| Interest Income | $10.00M | $13.00M | $16.00M | $13.00M |
| Interest Expense | $35.00M | $34.00M | $39.00M | $33.00M |
| Depreciation & Amortization | $234.00M | $322.00M | $211.00M | $239.00M |
| EBITDA | $128.00M | $196.00M | $302.00M | $323.00M |
| EBITDA Ratio | $0.04 | $0.06 | $0.08 | $0.09 |
| Operating Income | -$97.00M | -$191.00M | $41.00M | $68.00M |
| Operating Income Ratio | -$0.03 | -$0.06 | $0.01 | $0.02 |
| Other Income/Expenses (Net) | -$44.00M | $29.00M | $11.00M | -$29.00M |
| Income Before Tax | -$141.00M | -$162.00M | $52.00M | $51.00M |
| Income Before Tax Ratio | -$0.04 | -$0.05 | $0.01 | $0.01 |
| Income Tax Expense | $20.00M | $30.00M | $21.00M | $126.00M |
| Net Income | -$160.00M | -$192.00M | $33.00M | -$72.00M |
| Net Income Ratio | -$0.05 | -$0.06 | $0.009 | -$0.02 |
| EPS | -$0.85 | -$1.02 | $0.17 | -$0.38 |
| Diluted EPS | -$0.85 | -$1.02 | $0.17 | -$0.38 |
| Weighted Avg Shares Outstanding | $188.74M | $188.74M | $188.74M | $188.74M |
| Weighted Avg Shares Outstanding (Diluted) | $188.74M | $188.74M | $188.74M | $188.74M |
The company's financials show resilient growth, with revenue advancing from $3.69B in Q2 2024 to $3.48B in Q1 2025. Gross profit remained healthy with margins at 13% in Q1 2025 compared to 17% in Q2 2024. Operating income hit -$97.00M last quarter, sustaining a consistent -3% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $128.00M. Net income rose to -$160.00M, while earnings per share reached -$0.85. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan